Get the Stockscreener App
4.35
2.47%
-0.11
After Hours:
4.35
Bolt Biotherapeutics Inc stock is traded at $4.35, with a volume of 6,482.
It is down -2.47% in the last 24 hours and down -19.44% over the past month.
Bolt Biotherapeutics Inc is a clinical-stage immuno-oncology company. It is developing tumor-targeted therapies that leverage the power of the innate and adaptive immune systems. The company's pipeline candidates are built on deep expertise in myeloid biology and cancer drug development. The company's proprietary Boltbody ISAC platform technology combines tumor-targeting antibodies with immune-stimulating linker-payloads. The company's pipeline consists of BDC-1001, BDC-3042, and Next-Gen ISAC.
See More
Previous Close:
$4.46
Open:
$4.54
24h Volume:
6,482
Relative Volume:
0.22
Market Cap:
$8.35M
Revenue:
$4.17M
Net Income/Loss:
$-50.71M
P/E Ratio:
-0.3228
EPS:
-13.474
Net Cash Flow:
$-51.40M
1W Performance:
-6.05%
1M Performance:
-19.44%
6M Performance:
-16.18%
1Y Performance:
-51.12%
1-Day Range:
$4.34
$4.54
1-Week Range:
$4.31
$4.9999
52-Week Range:
$4.27
$9.66
Bolt Biotherapeutics Inc Stock (BOLT) Company Profile
Name
Bolt Biotherapeutics Inc
Sector
Industry
Phone
650-665-9295
Address
900 CHESAPEAKE DRIVE, REDWOOD CITY
Compare BOLT vs VRTX, REGN, ARGX, ALNY, ONC
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
BOLT
Bolt Biotherapeutics Inc
|
4.35 | 8.56M | 4.17M | -50.71M | -51.40M | -13.47 |
|
VRTX
Vertex Pharmaceuticals Inc
|
460.82 | 121.40B | 12.07B | 3.95B | 3.19B | 15.33 |
|
REGN
Regeneron Pharmaceuticals Inc
|
764.93 | 83.25B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
728.11 | 46.39B | 4.16B | 1.29B | 734.26M | 19.59 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
320.51 | 43.41B | 3.71B | 313.75M | 465.38M | 2.2571 |
|
ONC
Beone Medicines Ltd Adr
|
292.94 | 33.09B | 5.36B | 287.73M | 924.18M | 2.5229 |
Bolt Biotherapeutics Inc Stock (BOLT) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Oct-20-25 | Resumed | H.C. Wainwright | Buy |
| Jan-06-22 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Mar-02-21 | Initiated | Guggenheim | Buy |
| Mar-02-21 | Initiated | Morgan Stanley | Overweight |
| Mar-02-21 | Initiated | SVB Leerink | Outperform |
| Mar-02-21 | Initiated | Stifel | Buy |
View All
Bolt Biotherapeutics Inc Stock (BOLT) Latest News
BOLTBolt Biotherapeutics, Inc. Latest Stock News & Market Updates - Stock Titan
Is Bolt Biotherapeutics Inc likely to announce a buybackJuly 2025 Technicals & Reliable Trade Execution Plans - baoquankhu1.vn
BOLT SEC FilingsBolt Biotherapeutics, Inc. 10-K, 10-Q, 8-K Forms - Stock Titan
Portfolio Update: Will Bolt Biotherapeutics Inc announce a stock splitJuly 2025 Selloffs & Reliable Intraday Trade Alerts - baoquankhu1.vn
Bolt Biotherapeutics, Inc. (BOLT) Expected to Beat Earnings Estimates: Should You Buy? - MSN
Bolt Biotherapeutics to Participate in Upcoming March Conferences - Bitget
Ideas Watch: Is Bolt Biotherapeutics Inc a speculative investmentProduct Launch & Technical Pattern Alert System - baoquankhu1.vn
BOLT Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Layoff Tracker: Concerto Downsizes Amid Pivot to Consumer; Faraday Closes Down - BioSpace
Recap Report: Is TIM SA Depositary Receipt stock a hidden gemWeekly Profit Summary & Growth Focused Stock Pick Reports - baoquankhu1.vn
Is Bolt Biotherapeutics Inc. impacted by rising ratesIndex Update & Weekly Setup with ROI Potential - mfd.ru
Is Bolt Biotherapeutics Inc. likely to announce a buybackRecession Risk & Smart Money Movement Alerts - mfd.ru
Why Bolt Biotherapeutics Inc. (6LP0) stock stays undervaluedTrade Signal Summary & Community Supported Trade Ideas - mfd.ru
Is Bolt Biotherapeutics Inc. stock forming a cup and handleJuly 2025 Earnings & Intraday High Probability Setup Alerts - mfd.ru
Is Bolt Biotherapeutics Inc. a speculative investmentJuly 2025 WrapUp & Daily Profit Focused Screening - mfd.ru
H.C. Wainwright Raises Protagonist Therapeutics, Inc. (PTGX) Target to $117, Reiterates Buy - Finviz
Treasury Yields: Is Bolt Biotherapeutics Inc. a top pick in the sectorPortfolio Return Summary & AI Forecasted Stock Moves - baoquankhu1.vn
Radiopharm Theranostics (NASDAQ:RADX) versus Bolt Biotherapeutics (NASDAQ:BOLT) Head-To-Head Survey - Defense World
Wall Street Analysts Are Bullish on Top Healthcare Picks - The Globe and Mail
Bolt Biotherapeutics (NASDAQ:BOLT) Stock Passes Above 200 Day Moving Average – Should You Sell? - Defense World
Growth Review: What are the analyst revisions for Bolt Biotherapeutics Inc.Is ZKIN stock a good investment in YEARDollar Strength & Low Risk High Reward Ideas - baoquankhu1.vn
Is Bolt Biotherapeutics Inc. still a buy after recent gains2025 Momentum Check & Free High Accuracy Swing Entry Alerts - mfd.ru
Insider Trends: What is the long term forecast for Bolt Biotherapeutics Inc stockJuly 2025 Chart Watch & AI Powered Market Entry Ideas - baoquankhu1.vn
Risk Recap: Can ETRACS 2x Leveraged US Value Factor TR ETN maintain sales growth2025 Trade Ideas & Fast Entry and Exit Trade Plans - baoquankhu1.vn
Nasdaq Moves: Whats the outlook for Bolt Biotherapeutics Incs sector2025 Valuation Update & Technical Confirmation Trade Alerts - baoquankhu1.vn
Bolt (Fastener) Market Covering Prime Factors and Competitive - openPR.com
Risks Report: What are the analyst revisions for Bolt Biotherapeutics IncIs ZKIN stock a good investment in YEARMarket Growth Summary & Weekly Return Optimization Plans - baoquankhu1.vn
Is Bolt Biotherapeutics Inc a top pick in the sectorJuly 2025 Chart Watch & AI Based Trade Execution Alerts - baoquankhu1.vn
Weekly Recap: Can Quince Therapeutics Inc sustain its profitabilityJuly 2025 Price Swings & Low Risk High Reward Trade Ideas - baoquankhu1.vn
Portfolio Shifts: Is Bolt Biotherapeutics Inc a top pick in the sectorJuly 2025 Movers & Long Hold Capital Preservation Tips - baoquankhu1.vn
Aug Final Week: Does ELAB stock reflect fundamentalsBull Run & Expert Approved Momentum Trade Ideas - baoquankhu1.vn
Bolt appoints Olta Andoni as SVP of legal and people to support platform expansion across checkout, identity, and payments - marketscreener.com
Bolt Biotherapeutics, Inc. (NASDAQ:BOLT) Short Interest Down 83.8% in December - Defense World
Aug Analyst Calls: What momentum indicators show for Bolt Biotherapeutics Inc stockQuarterly Portfolio Report & AI Forecasted Stock Moves - Bộ Nội Vụ
Entry Recap: Will Bolt Biotherapeutics Inc. (6LP0) stock enhance shareholder valueMarket Volume Report & Advanced Technical Signal Analysis - Bộ Nội Vụ
Portfolio Shifts: Is Bolt Biotherapeutics Inc undervalued by DCF analysisJuly 2025 Chart Watch & Reliable Breakout Forecasts - baoquankhu1.vn
Analyst Calls: Why Bolt Biotherapeutics Inc 6LP0 stock fits value portfoliosJuly 2025 Price Swings & Verified High Yield Trade Plans - moha.gov.vn
Can Bolt Biotherapeutics Inc. stock continue upward trendWeekly Investment Summary & Real-Time Market Sentiment Alerts - Улправда
Will Bolt Biotherapeutics Inc. stock outperform tech sector in 2025Contrarian Investment Ideas & High Return Trading Strategies - bollywoodhelpline.com
Why Bolt Biotherapeutics Inc. (6LP0) stock fits value portfoliosPortfolio Profit Report & AI Driven Stock Movement Reports - ulpravda.ru
Can Bolt Biotherapeutics Inc. (6LP0) stock hold up in economic slowdownExit Point & Consistent Income Trade Ideas - ulpravda.ru
How Bolt Biotherapeutics Inc. stock performs after earningsJuly 2025 Pullbacks & Free Expert Approved Momentum Trade Ideas - Улправда
Will Eversource Energy (NWJ) stock maintain strong growthWeekly Stock Report & AI Optimized Trading Strategy Guides - Улправда
How supply shortages influence Bolt Biotherapeutics Inc. (6LP0) stockDividend Hike & Stepwise Entry/Exit Trade Alerts - ulpravda.ru
Will Bolt Biotherapeutics Inc. stock reach all time highs in 2025Earnings Overview Summary & Pattern Based Trade Signal System - Улправда
ulpravda ru > 2026> Is QLYS stock a buy on dipsEarnings Miss & Fast Gain Swing Alerts - Улправда
Should I hold or sell Contineum Therapeutics Inc. stock in 2025July 2025 Closing Moves & Safe Entry Momentum Tips - Улправда
Fundamentals Check: Can Bolt Biotherapeutics Inc. stock continue upward trend2025 Breakouts & Breakdowns & Verified Short-Term Plans - Улправда
Earnings Beat: Will Bolt Biotherapeutics Inc. stock reach all time highs in 2025Trade Entry Report & Free Technical Confirmation Trade Alerts - Улправда
Is Bolt Biotherapeutics Inc. stock supported by innovation pipelineJuly 2025 Update & Weekly High Return Opportunities - ulpravda.ru
SMA structure is bullish with the price reclaiming key MAs.Day Trading Setups & Affordable Market Strategies - ulpravda.ru
Bolt Biotherapeutics Inc Stock (BOLT) Financials Data
Revenue
Net Income
Cash Flow
EPS
3.69%
0.68%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):